CAD 0.03
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 10.08 Million CAD | 6.93% |
2022 | 9.42 Million CAD | 5.83% |
2021 | 8.9 Million CAD | 13.02% |
2020 | 7.88 Million CAD | 5.35% |
2019 | 7.48 Million CAD | 22.38% |
2018 | 6.11 Million CAD | 423.24% |
2017 | 1.16 Million CAD | 206.14% |
2016 | 381.61 Thousand CAD | -33.19% |
2015 | 571.22 Thousand CAD | 58.09% |
2014 | 361.33 Thousand CAD | -43.06% |
2013 | 634.58 Thousand CAD | -6.24% |
2012 | 676.83 Thousand CAD | -6.44% |
2011 | 723.44 Thousand CAD | 33.55% |
2010 | 541.7 Thousand CAD | -45.01% |
2009 | 985.11 Thousand CAD | 258.41% |
2008 | 274.85 Thousand CAD | 89.63% |
2007 | 144.94 Thousand CAD | 53.43% |
2006 | 94.46 Thousand CAD | -46.65% |
2005 | 177.06 Thousand CAD | 539.33% |
2004 | 27.69 Thousand CAD | 219.52% |
2003 | 8668.00 CAD | 67.47% |
2002 | 5176.00 CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 10.12 Million CAD | 0.4% |
2024 Q2 | 10.13 Million CAD | 0.1% |
2023 Q2 | 10.04 Million CAD | 4.04% |
2023 Q4 | 10.08 Million CAD | -0.91% |
2023 Q1 | 9.65 Million CAD | 2.42% |
2023 Q3 | 10.17 Million CAD | 1.27% |
2023 FY | 10.08 Million CAD | 6.93% |
2022 Q3 | 9.44 Million CAD | 3.17% |
2022 Q4 | 9.42 Million CAD | -0.17% |
2022 FY | 9.42 Million CAD | 5.83% |
2022 Q1 | 8.69 Million CAD | -2.41% |
2022 Q2 | 9.15 Million CAD | 5.29% |
2021 Q1 | 8.5 Million CAD | 7.95% |
2021 Q3 | 8.5 Million CAD | 0.5% |
2021 Q2 | 8.46 Million CAD | -0.48% |
2021 Q4 | 8.9 Million CAD | 4.69% |
2021 FY | 8.9 Million CAD | 13.02% |
2020 Q2 | 7.09 Million CAD | 1.67% |
2020 Q4 | 7.88 Million CAD | 11.32% |
2020 FY | 7.88 Million CAD | 5.35% |
2020 Q1 | 6.98 Million CAD | -6.66% |
2020 Q3 | 7.08 Million CAD | -0.27% |
2019 FY | 7.48 Million CAD | 22.38% |
2019 Q1 | 6.33 Million CAD | 3.66% |
2019 Q4 | 7.48 Million CAD | 4.51% |
2019 Q3 | 7.15 Million CAD | 11.02% |
2019 Q2 | 6.44 Million CAD | 1.75% |
2018 Q3 | 3.66 Million CAD | 39.94% |
2018 FY | 6.11 Million CAD | 423.24% |
2018 Q4 | 6.11 Million CAD | 66.69% |
2018 Q2 | 2.62 Million CAD | 68.99% |
2018 Q1 | 1.55 Million CAD | 32.73% |
2017 FY | 1.16 Million CAD | 206.14% |
2017 Q1 | 311.14 Thousand CAD | -18.47% |
2017 Q4 | 1.16 Million CAD | 132.17% |
2017 Q2 | 357.67 Thousand CAD | 14.95% |
2017 Q3 | 503.18 Thousand CAD | 40.68% |
2016 Q4 | 381.61 Thousand CAD | -28.09% |
2016 FY | 381.61 Thousand CAD | -33.19% |
2016 Q2 | 489.17 Thousand CAD | -31.11% |
2016 Q1 | 710.07 Thousand CAD | 24.31% |
2016 Q3 | 530.7 Thousand CAD | 8.49% |
2015 Q2 | 571.81 Thousand CAD | 31.93% |
2015 Q1 | 433.41 Thousand CAD | 19.95% |
2015 FY | 571.22 Thousand CAD | 58.09% |
2015 Q4 | 571.22 Thousand CAD | -17.45% |
2015 Q3 | 691.94 Thousand CAD | 21.01% |
2014 Q3 | 324.32 Thousand CAD | -27.01% |
2014 FY | 361.33 Thousand CAD | -43.06% |
2014 Q1 | 385.51 Thousand CAD | -39.25% |
2014 Q2 | 444.33 Thousand CAD | 15.26% |
2014 Q4 | 361.33 Thousand CAD | 11.41% |
2013 Q4 | 634.58 Thousand CAD | -29.25% |
2013 FY | 634.58 Thousand CAD | -6.24% |
2013 Q3 | 896.99 Thousand CAD | 11.62% |
2013 Q2 | 803.62 Thousand CAD | 8.99% |
2013 Q1 | 737.32 Thousand CAD | 8.94% |
2012 Q3 | 555.49 Thousand CAD | -7.01% |
2012 FY | 676.83 Thousand CAD | -6.44% |
2012 Q4 | 676.83 Thousand CAD | 21.84% |
2012 Q2 | 597.37 Thousand CAD | -15.47% |
2012 Q1 | 706.73 Thousand CAD | 0.0% |
2011 Q3 | 490.13 Thousand CAD | 18.91% |
2011 FY | 723.44 Thousand CAD | 33.55% |
2011 Q1 | 423.77 Thousand CAD | -21.77% |
2011 Q2 | 412.19 Thousand CAD | -2.73% |
2010 Q3 | 369.72 Thousand CAD | -65.43% |
2010 Q2 | 1.06 Million CAD | 15.44% |
2010 Q1 | 926.41 Thousand CAD | -5.96% |
2010 Q4 | 541.7 Thousand CAD | 46.51% |
2010 FY | 541.7 Thousand CAD | -45.01% |
2009 Q4 | 985.11 Thousand CAD | -0.15% |
2009 Q2 | 574.26 Thousand CAD | 12.6% |
2009 Q1 | 509.98 Thousand CAD | 85.55% |
2009 FY | 985.11 Thousand CAD | 258.41% |
2009 Q3 | 986.64 Thousand CAD | 71.81% |
2008 Q3 | 20.93 Thousand CAD | -58.86% |
2008 Q4 | 274.85 Thousand CAD | 1213.22% |
2008 Q1 | 389.23 Thousand CAD | 168.55% |
2008 Q2 | 50.87 Thousand CAD | -86.93% |
2008 FY | 274.85 Thousand CAD | 89.63% |
2007 Q1 | 114.13 Thousand CAD | 20.82% |
2007 Q4 | 144.94 Thousand CAD | -46.7% |
2007 FY | 144.94 Thousand CAD | 53.43% |
2007 Q2 | 301.47 Thousand CAD | 164.13% |
2007 Q3 | 271.91 Thousand CAD | -9.8% |
2006 Q3 | 235.62 Thousand CAD | 150.92% |
2006 FY | 94.46 Thousand CAD | -46.65% |
2006 Q2 | 93.9 Thousand CAD | 86.84% |
2006 Q1 | 50.26 Thousand CAD | -71.62% |
2006 Q4 | 94.46 Thousand CAD | -59.91% |
2005 FY | 177.06 Thousand CAD | 539.33% |
2005 Q4 | 177.06 Thousand CAD | -39.26% |
2005 Q3 | 291.52 Thousand CAD | 323.45% |
2005 Q1 | 55.09 Thousand CAD | 98.91% |
2005 Q2 | 68.84 Thousand CAD | 24.97% |
2004 Q1 | 35.59 Thousand CAD | 310.59% |
2004 Q2 | 53.03 Thousand CAD | 49.0% |
2004 Q3 | 76.33 Thousand CAD | 43.95% |
2004 FY | 27.69 Thousand CAD | 219.52% |
2004 Q4 | 27.69 Thousand CAD | -63.72% |
2003 Q3 | 7663.00 CAD | -13.22% |
2003 Q4 | 8668.00 CAD | 13.11% |
2003 Q2 | 8830.00 CAD | 5.52% |
2003 Q1 | 8368.00 CAD | 0.0% |
2003 FY | 8668.00 CAD | 67.47% |
2002 FY | 5176.00 CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | -243.298% |
Ayurcann Holdings Corp. | 14.31 Million CAD | 29.597% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -2041.588% |
The BC Bud Corporation | 626 Thousand CAD | -1510.365% |
BioNxt Solutions Inc. | 6.55 Million CAD | -53.902% |
CordovaCann Corp. | 11.29 Million CAD | 10.716% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | -18.585% |
Captor Capital Corp. | 28.76 Million CAD | 64.954% |
City View Green Holdings Inc. | 3.73 Million CAD | -170.051% |
1CM Inc. | 9.42 Million CAD | -6.975% |
Global Hemp Group Inc. | 5.82 Million CAD | -73.059% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 52.39% |
IM Cannabis Corp. | 35.11 Million CAD | 71.29% |
Lobe Sciences Ltd. | 2.45 Million CAD | -309.858% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -3807.344% |
Nextleaf Solutions Ltd. | 4.4 Million CAD | -128.938% |
Ovation Science Inc. | 728.99 Thousand CAD | -1282.861% |
Pharmadrug Inc. | 2.92 Million CAD | -244.592% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | -382.583% |
RAMM Pharma Corp. | 2.83 Million CAD | -255.525% |
RIV Capital Inc. | 275.63 Million CAD | 96.343% |
Revive Therapeutics Ltd. | 3.4 Million CAD | -196.156% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | 97.235% |
SLANG Worldwide Inc. | 37.58 Million CAD | 73.177% |
1933 Industries Inc. | 23.28 Million CAD | 56.702% |
Red Light Holland Corp. | 3.82 Million CAD | -163.785% |
Top Strike Resources Corp. | 20.99 Million CAD | 51.982% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -1176.142% |
Adastra Holdings Ltd. | 17.65 Million CAD | 42.909% |